2.5707
price up icon0.78%   0.0007
 
loading
전일 마감가:
$2.57
열려 있는:
$2.56
하루 거래량:
25,586
Relative Volume:
0.15
시가총액:
$18.29M
수익:
$2.90M
순이익/손실:
$87.91M
주가수익비율:
0.1647
EPS:
15.6103
순현금흐름:
$-26.93M
1주 성능:
-0.38%
1개월 성능:
+15.11%
6개월 성능:
+82.39%
1년 성능:
-48.10%
1일 변동 폭
Value
$2.53
$2.6701
1주일 범위
Value
$2.47
$3.10
52주 변동 폭
Value
$0.97
$19.44

Traws Pharma Inc Stock (TRAW) Company Profile

Name
명칭
Traws Pharma Inc
Name
전화
267-759-3680
Name
주소
12 PENNS TRAIL, NEWTOWN
Name
직원
7
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TRAW's Discussions on Twitter

TRAW을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TRAW
Traws Pharma Inc
2.5899 18.31M 2.90M 87.91M -26.93M 15.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
423.74 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
640.57 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
444.54 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
824.40 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
183.00 40.44B 447.02M -1.18B -868.57M -6.1812

Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-03-01 개시 Ladenburg Thalmann Buy
2021-05-18 개시 Guggenheim Buy
2018-03-01 재확인 H.C. Wainwright Buy
2018-01-17 다운그레이드 Maxim Group Buy → Hold
2017-10-09 개시 H.C. Wainwright Buy
2017-04-27 개시 Laidlaw Buy
2015-07-01 업그레이드 Piper Jaffray Neutral → Overweight
2015-05-05 개시 H.C. Wainwright Buy
모두보기

Traws Pharma Inc 주식(TRAW)의 최신 뉴스

pulisher
04:39 AM

Why ETFs are accumulating Traws Pharma Inc. (0T20) stockIndex Update & Fast Exit/Entry Strategy Plans - newser.com

04:39 AM
pulisher
03:42 AM

Visualizing Traws Pharma Inc. stock with heatmapsTrade Performance Summary & Consistent Income Trade Ideas - newser.com

03:42 AM
pulisher
02:23 AM

Measuring Traws Pharma Inc.’s beta against major indicesWatch List & Fast Gaining Stock Strategy Reports - newser.com

02:23 AM
pulisher
Nov 02, 2025

What the charts say about Traws Pharma Inc. todayExit Point & Stepwise Trade Signal Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using RSI to spot recovery in Traws Pharma Inc.2025 Top Decliners & Weekly Top Gainers Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Traws Pharma Inc. (0T20) stock supported by free cash flowJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Traws Pharma Inc. (0T20) stock testing key supportJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Live market analysis of Traws Pharma Inc.2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What technical models suggest about Traws Pharma Inc.’s comebackEarnings Growth Report & Risk Controlled Daily Plans - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Traws Pharma Inc. (0T20) stock extend growth storyJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Price action breakdown for Traws Pharma Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Traws Pharma Inc. forming a reversal patternMarket Activity Report & High Accuracy Investment Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Traws Pharma (NASDAQ:TRAW) Upgraded at Wall Street Zen - Defense World

Nov 01, 2025
pulisher
Oct 31, 2025

Tick level data insight on Traws Pharma Inc. volatilityPortfolio Gains Summary & Breakout Confirmation Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Traws Pharma Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is a relief rally coming for Traws Pharma Inc. holdersWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials - MarketScreener

Oct 30, 2025
pulisher
Oct 30, 2025

2025-10-30 | ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials | NDAQ:TRAW | Press Release - Stockhouse

Oct 30, 2025
pulisher
Oct 30, 2025

Advanced analytics toolkit walkthrough for Traws Pharma Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com

Oct 30, 2025
pulisher
Oct 28, 2025

How Traws Pharma Inc. stock reacts to inflationary pressuresWeekly Trade Report & Verified Technical Trade Signals - newser.com

Oct 28, 2025

Traws Pharma Inc (TRAW) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.52
price up icon 0.03%
$93.16
price down icon 0.32%
$28.84
price up icon 0.79%
$104.30
price up icon 0.20%
biotechnology ONC
$313.33
price up icon 0.97%
$184.11
price down icon 2.65%
자본화:     |  볼륨(24시간):